koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - agenți antineoplazici - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
fluenz tetra
astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - gripa, umană - vaccinurile împotriva gripei, gripa, viu atenuat - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. utilizarea fluenz tetra trebuie să se bazeze pe recomandările oficiale.
zoladex 3,6 mg implant
astrazeneca ab - goserelinum - implant - 3,6 mg
imfinzi 50 mg ml 120 mg/2,4 ml concentrat pentru soluţie perfuzabilă
astrazeneca ab - durvalumabum - concentrat pentru soluţie perfuzabilă - 120 mg/2,4 ml
imfinzi 50 mg ml 500 mg/10 ml concentrat pentru soluţie perfuzabilă
astrazeneca ab - durvalumabum - concentrat pentru soluţie perfuzabilă - 500 mg/10 ml
bydureon 2 mg
astrazeneca ab - suedia - exenatidum - susp. inj. cu elib. prel. in stilou injector (pen) - 2mg - analogi ai glp-1
byetta 10µg/doza
astrazeneca ab - suedia - exenatidum - sol. inj. in stilou injector preumplut - 10µg/doza - analogi ai glp-1
byetta 5µg/doza
astrazeneca ab - suedia - exenatidum - sol. inj. in stilou injector preumplut - 5µg/doza - analogi ai glp-1
calquence 100 mg
astrazeneca ab - suedia - acalabrutinibum - caps. - 100mg - inhibitori de protein-kinaza
calquence 100 mg
astrazeneca ab - suedia - acalabrutinibum - compr. film. - 100mg - inhibitori de protein-kinaza